Latest episode
Transforming clinical trials: We meet Dr Melanie Ivarsson, from the global biotechnology company Moderna, to find out why she chose the UK for a billion-pound research and development program
20:01As the UK transforms its ecosystem for clinical trials, the regulatory landscape is undergoing its biggest change in 20 years. In this third episode of this free New Scientist podcast, we meet Dr Melanie Ivarsson, from the global biotechnology company Moderna, to find out why she chose the UK for a billion-pound research and development program. Sponsored by the UK Department for Business and Trade and the Medicines and Healthcare products Regulatory Agency
More episodes
View all episodes
Transforming clinical trials: We meet Prof Andrea Manfrin whose team is responsible for driving change at the Medicines and Healthcare products Regulatory Agency
18:23As the UK transforms its ecosystem for clinical trials, the regulatory landscape is undergoing its biggest change in 20 years. In this free New Scientist podcast, we meet Professor Andrea Manfrin whose team is responsible for driving this change at the Medicines and Healthcare products Regulatory Agency. Sponsored by the UK Department for Business and Trade and the Medicines and Healthcare products Regulatory AgencyTransforming clinical trials: We ask James O'Shaughnessy how the UK independent review has influenced the reinvention of the clinical trials infrastructure
30:11The UK has long been a world leader for clinical trials and life sciences research. But after losing ground post-COVID and post-Brexit, the country has begun to rethink the landscape for clinical trials. In this free New Scientist podcast, we meet the chair of the UK review into commercial clinical trials, James O'Shaughnessy, and ask how the independent review has influenced the reinvention of the clinical trials infrastructure for a new age of medicine.Sponsored by the UK Department for Business and Trade and the Medicines and Healthcare products Regulatory Agency